GILEAD SCIENCES, INC. — Director's Dealing 2016

Apr 21, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2016-04-19

Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-19	Common Stock	M	35874	$26.99	Acquired	177964	Direct
2016-04-19	Common Stock	S	35874	$100.016	Disposed	142090	Direct
2016-04-19	Common Stock	S	4126	$100.00	Disposed	137964	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-19	Non-qualified Stock Option (Right to Buy)	$26.99	M	35874	Disposed	2018-07-30	Common Stock (35874)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: Options vest over a five year period with 20% vesting July 30, 2009, the first anniversary of the grant. The options continue to vest in quarterly installments over the next four years, and will be fully vested on July 30, 2013.

F3: Sale prices reported for the transactions reported here range from $100.00 to $100.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.